Spartanburg Regional Healthcare System (SRHS) Deploys 2bPrecise Enterprise
Multi-year partnership affirms SHRS as a leader in precision care and genomics SPARTANBURG, S.C. and HOUSTON, June 25, 2025 /PRNewswire/ -- Spartanburg...
Staff
Corundum Convergence Institute and the University of Tokyo’s International Research Center for Neurointelligence Launch Inaugural Neuroscience Entrepreneurship Workshop
Neuro-inspired Computation and Entrepreneurship Workshop Will Equip the Next Generation of Neuroscience Entrepreneurs with Foundational Tools for Startup Creation TOKYO,...
ALR Technologies Completes Definitive Manufacturing Agreement for GluCurve Pet CGM
SINGAPORE, June 25, 2025 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCPK: ALRTF), the diabetes management company,...
Karen Renzi Joins ProofPilot as Vice President, Clinical Strategy & Solutions
NEW YORK, June 25, 2025 /PRNewswire/ -- ProofPilot, the leading end-to-end Clinical Experience Platform (CXP), is pleased to announce the...
Nephrolytics Closes $2.5M SAFE Round, Launches Saya™ First Full Stack Agentic Solution for Kidney Disease Care, and Showcases Breakthrough at RPA 2025
CHUBBUCK, Idaho, June 25, 2025 /PRNewswire/ -- Nephrolytics, Inc., the AI-powered clinical intelligence platform revolutionizing kidney care, today announced three...
PUBLICIS HEALTH NAMES NEW EXECUTIVE LEADERSHIP AT SAATCHI & SAATCHI WELLNESS
Agency names Brendan Gallagher, Beth Bour, and Divya Dileep to executive leadership roles in strategic move to support its growth...
Gotcha Covered opens fourth franchise location in Georgia
Owner Laura Maniccia hopes Gotcha Covered Newnan Peachtree City will help homeowners make their homes a personal oasis ATLANTA, June...
Dimension Ortho and Rothman Orthopaedics Launch Strategic Partnership to Redefine Orthotic Care with 3D Printing
PHILADELPHIA, June 25, 2025 /PRNewswire/ -- Dimension Ortho, the global leader in 3D printed orthotics, has announced a strategic partnership with...
Bio-Thera Solutions Announces First Patient Dosed in Phase 3 Clinical Trial for BAT8006, an Antibody Drug Conjugate Targeting Folate Receptor α for the Treatment of Platinum-Resistant Ovarian Cancer
GUANGZHOU, China, June 25, 2025 /PRNewswire/ - Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and...
Slide Stainers Market to Reach $5.53 Billion by 2032, Growing at a CAGR of 7.9% from 2025, Says Meticulous Research®
Market Growth Driven by Rising Geriatric Population, Chronic Disease Burden, Laboratory Automation Demand, and Advanced Diagnostic Technology Integration REDDING, Calif.,...
Unbuzzd Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering
Engages leading marketing firm MZ Digital and crowdfunding platform Dealmaker to successfully execute raise.Vancouver, British Columbia--(Newsfile Corp. - June 25,...
Unbuzzd Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering
Engages leading marketing firm MZ Digital and crowdfunding platform Dealmaker to successfully execute raise.Vancouver, British Columbia--(Newsfile Corp. - June 25,...
Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Collaboration with MD Anderson Cancer Center
Preclinical data demonstrate potent single-agent and combination effects in head and neck squamous cell carcinoma (HNSCC) models, including synergy with...
Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Collaboration with MD Anderson Cancer Center
Preclinical data demonstrate potent single-agent and combination effects in head and neck squamous cell carcinoma (HNSCC) models, including synergy with...
Commure Launches Commure Agents – AI Assistants That Fully Automate Physician Workflows
Epic-integrated solution pioneers the industry’s shift from copilot to autopilot, ushering in the future of clinical automationMOUNTAIN VIEW, Calif., June...
Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
--European CE mark approval of the entire FemBloc® system marks pivotal achievement in expanding safe, accessible and non-surgical permanent contraceptive...
Akari Therapeutics Releases Virtual Investor “What This Means” Segment Highlighting its Recently Granted India Patent
Access the “What This Means” segment here BOSTON and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq:...
INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent
SARASOTA, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare...
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
Technology Co-Developed by the U.S. Department of Veterans Affairs and Emory University NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) --...
Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
June 25, 2025 Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis...